« Back
Home /
Omalizumab Biosimilar(Anti-IgE Reference Antibody)

Omalizumab Biosimilar(Anti-IgE Reference Antibody)

Item no.	DCC-A015-100mg
Manufacturer	DCChemicals
CASRN	242138-07-4
Amount	100 mg
Quantity options	100 mg 10 mg 25 mg
Category	ELISA Reagents & Chemicals Molecules Immunostaining
Type	Chemicals
Applications	ELISA
Specific against	other
Smiles	OC1CCC(=C)C(=CC(C)(C)C)C1.OC1CCC(=C)C(=CC(C)(C)C)C1.OC1C(=C)C(=CC(C)(C)C)CCC1.OC1C(=C)C(=CC(C)(C)C)CCC1
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	242138-07-4
Similar products	242138-07-4
Available
Manufacturer - Applications	Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human immunoglobulin (Ig)E to treat an asthma attack.
Manufacturer - Category	Therapeutic Antibodies
Molecular Weight	721, 146415710449

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 9/25/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Get an offer